Análisis de la acción Cellebrite DI Ltd (CLBT)CLBTCellebrite DI Ltd

Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. It operates in the Technology sector.

Cellebrite DI Ltd is currently priced at $12.1, showing a recent 5-day change of +9.70%. However, with an RSI of 74.536 indicating overbought conditions and a forward P/E of 35.7143, the stock may be overvalued in the short term. The company has reported a significant decline in net income with Q2 2026 net income dropping to $6.37 million, down from previous quarters, raising concerns about future profitability. The main risk is the lowered 2026 ARR guidance to $550-$560 million, reflecting challenges in revenue growth.